Stock Rating Upgrade
Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Biogen Inc (NASDAQ: BIIB) improved of late. BIIB’s current Value Trend Rating is C and the prior Rating was D. Details supporting this higher rating are included in our next report.
Recent Price Action
Biogen Inc (NASDAQ: BIIB) stock closed at $140.55 on 1/17/25 after a slight decline of -0.5%. However, below average trading volume at 76% of normal accompanied the decline. The stock has declined -6.8% during the last week and has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Biogen has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Biogen has a good Appreciation Score of 80 but a very low Power Rating of 9, producing the Low Neutral Value Trend Rating.
Be the first to comment